Melanie Rietenbach
Global Product Manager, Immunotherapy • Miltenyi Biotec
Melanie Rietenbach is Global Product Manager for the Immunotherapy portfolio at Miltenyi Biotec. During the 3 years, she has been working together with the R&D and Clinical Development Team in order to advance the development of tools to enable engineered T cell immunotherapy. Before that, Melanie already supported Miltenyi Biotec in her role as Application Development Specialist and Clinical Product Specialist for more than three years. During that time, she was responsible for technical support and application training on Miltenyi Biotec’s clinical product portfolio with focus on cell and gene therapy applications and related products
Also Speaking
Peter Peumans
1 December 2022
Carl H. June
Director of the Center for Cellular Immunotherapies at the Perelman School of Medicine • University of Pennsylvania
18 November 2022
Also Speaking
Investor List
Take a look at some of the investors who attended Advanced Therapies Week 2023.
6 January 2023
